p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells

J Immunol. 1999 Apr 1;162(7):3819-29.

Abstract

Optimal T cell activation requires two signals, one generated by TCR and another by the CD28 costimulatory receptor. In this study, we investigated the regulation of costimulation-induced mitogen-activated protein kinase (MAPK) activation in primary mouse T cells. In contrast to that reported for human Jurkat T cells, we found that p38 MAPK, but not Jun NH2-terminal kinase (JNK), is weakly activated upon stimulation with either anti-CD3 or anti-CD28 in murine thymocytes and splenic T cells. However, p38 MAPK is activated strongly and synergistically by either CD3/CD28 coligation or PMA/Ca2+ ionophore stimulation, which mimics TCR-CD3/CD28-mediated signaling. Activation of p38 MAPK correlates closely with the stimulation of T cell proliferation. In contrast, PMA-induced JNK activation is inhibited by Ca2+ ionophore. T cell proliferation and production of IL-2, IL-4, and IFN-gamma induced by both CD3 and CD3/CD28 ligation and the nuclear expression of the c-Jun and ATF-2 proteins are each blocked by the p38 MAPK inhibitor SB203580. Our findings demonstrate that p38 MAPK 1) plays an important role in signal integration during costimulation of primary mouse T cells, 2) may be involved in the induction of c-Jun activation and augmentation of AP-1 transcriptional activity, and 3) regulates whether T cells enter a state of functional unresponsiveness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2
  • Animals
  • CD28 Antigens / immunology*
  • CD3 Complex / immunology
  • CD3 Complex / metabolism
  • Calcium / physiology
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Cell Nucleus / drug effects
  • Cell Nucleus / enzymology
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein / antagonists & inhibitors
  • Cyclic AMP Response Element-Binding Protein / biosynthesis
  • Cytokines / antagonists & inhibitors
  • Cytokines / metabolism
  • Drug Synergism
  • Enzyme Activation
  • Humans
  • Imidazoles / pharmacology
  • JNK Mitogen-Activated Protein Kinases
  • Jurkat Cells
  • Lymphocyte Activation* / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinases*
  • Proto-Oncogene Proteins c-jun / antagonists & inhibitors
  • Proto-Oncogene Proteins c-jun / biosynthesis
  • Pyridines / pharmacology
  • Receptors, Antigen, T-Cell / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / enzymology*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / biosynthesis
  • p38 Mitogen-Activated Protein Kinases

Substances

  • ATF2 protein, human
  • Activating Transcription Factor 2
  • Atf2 protein, mouse
  • CD28 Antigens
  • CD3 Complex
  • Cyclic AMP Response Element-Binding Protein
  • Cytokines
  • Imidazoles
  • Proto-Oncogene Proteins c-jun
  • Pyridines
  • Receptors, Antigen, T-Cell
  • Transcription Factors
  • Calcium-Calmodulin-Dependent Protein Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • Calcium